AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29178702 — intervention group
Group type: EXPERIMENTAL
Intervention: fluoride‐containing self‐etch adhesive ‐ Clearfil SE Protect
Number of subjects: 30
Study 29178702 — intervention group
Group type: EXPERIMENTAL
Intervention: glutaraldehyde‐containing etch‐and‐rinse adhesive ‐ Gluma 2 Bond
Number of subjects: 30
Study 25872972 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 652
Study 25872972 — intervention group
Group type: COMPARATOR
Intervention: Abacavir/lamivudine
Number of subjects: 652
Study 24298524 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP (Scaling and Root Planing) + DOX nanofibers
Number of subjects: 7
Study 24298524 — intervention group
Group type: COMPARATOR
Intervention: SRP (Scaling and Root Planing) alone
Number of subjects: 7
Study 19462498 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin (once-daily bedtime dose added to current medication)
Number of subjects: 611
Study 19462498 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued current medication)
Number of subjects: 611
Study 17261454 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic monitoring of adherence
Number of subjects: 258
Study 17261454 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 258
Study 15161690 — intervention group
Group type: EXPERIMENTAL
Intervention: SU5416 (145 mg/m(2)) and dexamethasone premedication
Number of subjects: 36
Study 15161690 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone alone
Number of subjects: 36
Study 12389002 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal misoprostol 600 microg
Number of subjects: 1606
Study 12389002 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin 10 IU plus methylergometrine
Number of subjects: 1606
Study 12389002 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin 10 IU
Number of subjects: 1606
Study 9872248 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 41
Study 9872248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 8590531 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 182
Study 8590531 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline solution)
Number of subjects: 182
Study 8590531 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone (nonresponders)
Number of subjects: 182
Study 8590531 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nonresponders)
Number of subjects: 182
Study 2487537 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nifedipine and prazosin
Number of subjects: 12
Study 2487537 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin pretreatment
Number of subjects: 12
Study 2487537 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine pretreatment
Number of subjects: 12
Study 2487537 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin as first drug and nifedipine as second drug
Number of subjects: 12
Study 342924 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuprol (3 capsules daily for 14 days)
Number of subjects: 50
Study 31401929 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative digital dilatation of cervix
Number of subjects: 0
Study 31401929 — intervention group
Group type: COMPARATOR
Intervention: Non-cervical dilatation
Number of subjects: 0
Study 31912780 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate
Number of subjects: 1107
Study 28029317 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy
Number of subjects: 201
Study 28029317 — intervention group
Group type: COMPARATOR
Intervention: Primary surgery
Number of subjects: 201
Study 26166533 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Gow‐Gates technique
Number of subjects: 206
Study 26166533 — intervention group
Group type: COMPARATOR
Intervention: Halstead technique
Number of subjects: 206
Study 23464658 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with propofol and remifentanil (TIVA)
Number of subjects: 112
Study 23464658 — intervention group
Group type: COMPARATOR
Intervention: Inhalational sevoflurane anesthesia (SEVO)
Number of subjects: 112
Study 23464658 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects experiencing ED
Number of subjects: 112
Study 21095134 — intervention group
Group type: EXPERIMENTAL
Intervention: Transit-time flow measurement (TTFM)
Number of subjects: 75
Study 19342206 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan 7.5 mg/d
Number of subjects: 33
Study 19342206 — intervention group
Group type: COMPARATOR
Intervention: Propranolol 120 mg/d
Number of subjects: 33
Study 17618080 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse‐assisted symptom management (NASM)
Number of subjects: 435
Study 17618080 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated telephone symptom management (ATSM)
Number of subjects: 435
Study 15377579 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 2 mg ml(‐1) and fentanyl 5 microg ml(‐1) with clonidine 2 microg ml(‐1) (Group RFC)
Number of subjects: 69
Study 15377579 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 2 mg ml(‐1) and fentanyl 5 microg ml(‐1) without clonidine (Group RF)
Number of subjects: 69
Study 11593098 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 86
Study 11593098 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 86
Study 9702404 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusional high-dose 5-fluorouracil (5-FU)
Number of subjects: 0
Study 9702404 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study 9702404 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment modality (surgery + chemotherapy)
Number of subjects: 0
Study 9702404 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant chemotherapy
Number of subjects: 0
Study 9702404 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 0
Study 9702404 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal postoperative treatment
Number of subjects: 0
Study 7991724 — intervention group
Group type: COMPARATOR
Intervention: Placebo control condition
Number of subjects: 0
Study 2660473 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole prophylaxis (n = 172)
Number of subjects: 376
Study 2660473 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 204)
Number of subjects: 376
Study 31034580 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum ear acupuncture plus standard obstetric care
Number of subjects: 220
Study 28523987 — intervention group
Group type: EXPERIMENTAL
Intervention: Early provision of ankle-foot orthosis (at inclusion; week 1)
Number of subjects: 33
Study 28523987 — intervention group
Group type: COMPARATOR
Intervention: Delayed provision of ankle-foot orthosis (eight weeks later; week 9)
Number of subjects: 33
Study 24659472 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue-tolerable plasma (TTP)
Number of subjects: 34
Study 24659472 — intervention group
Group type: EXPERIMENTAL
Intervention: Octenidine dihydrochloride (ODC)
Number of subjects: 34
Study 24659472 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of TTP and ODC
Number of subjects: 34
Study 23512821 — intervention group
Group type: EXPERIMENTAL
Intervention: SenseWear armband (SWA) Pro 2, version SWA 5.1
Number of subjects: 62
Study 23512821 — intervention group
Group type: EXPERIMENTAL
Intervention: SenseWear armband (SWA) Pro 2, version SWA 6.1
Number of subjects: 62
Study 22092477 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity laser therapy (LILT) applied with a diode laser (588 nm) before and immediately after surgery, and for 5 min daily for 7 days post-operatively
Number of subjects: 10
Study 22092477 — intervention group
Group type: COMPARATOR
Intervention: Control group (no LILT)
Number of subjects: 10
Study 18400982 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily oral methylphenidate
Number of subjects: 0
Study 18400982 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal methylphenidate
Number of subjects: 0
Study 18400982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17701685 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronotherapeutic strategies (timed administration of antihypertensive medication)
Number of subjects: 3000
Study 17701685 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronotherapeutic strategies
Number of subjects: 3000
Study 14980748 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual medical care plus intensive intervention implemented by a nurse case manager (NCM)/community health worker (CHW) team
Number of subjects: 542
Study 14980748 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care plus minimal telephone intervention implemented by a trained lay health educator
Number of subjects: 542
Study 12202673 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clodronate
Number of subjects: 0
Study 12202673 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous pamidronate
Number of subjects: 0
Study 12202673 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous zoledronic acid
Number of subjects: 0
Study 12202673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12202673 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous pamidronate or zoledronic acid
Number of subjects: 0
Study 9524044 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril 2 mg once daily
Number of subjects: 119
Study 9524044 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg once daily
Number of subjects: 119
Study 9524044 — intervention group
Group type: COMPARATOR
Intervention: Placebo after drug discontinuation
Number of subjects: 119
Study 16353582 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 1026
Study 16353582 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1026
Study 2767910 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned play periods (four periods)
Number of subjects: 60
Study 2767910 — intervention group
Group type: COMPARATOR
Intervention: Regular ward stimuli (control group)
Number of subjects: 60
Study 336648 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM) technique, practiced twice daily for 2 weeks
Number of subjects: 33
Study 336648 — intervention group
Group type: COMPARATOR
Intervention: Passive relaxation, practiced twice daily for 2 weeks
Number of subjects: 33
Study 31785830 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous chemo-radiotherapy
Number of subjects: 2297
Study 31785830 — intervention group
Group type: COMPARATOR
Intervention: Sequential chemo-radiotherapy
Number of subjects: 2297
Study 31785830 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous chemo-radiotherapy (anthracycline-CMF subgroup)
Number of subjects: 2297
Study 31785830 — intervention group
Group type: COMPARATOR
Intervention: Sequential chemo-radiotherapy (anthracycline-CMF subgroup)
Number of subjects: 2297
Study 29272072 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 29
Study 29272072 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training (END)
Number of subjects: 29
Study 29272072 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 29
Study 25969453 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling intervention of up to 12 weeks to support smoking reduction and increased physical activity
Number of subjects: 99
Study 25969453 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 99
Study 24568299 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 320
Study 24568299 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Therapy
Number of subjects: 320
Study 24568299 — intervention group
Group type: COMPARATOR
Intervention: Education
Number of subjects: 320
Study 22339103 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV‐BF
Number of subjects: 43
Study 22339103 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow abdominal breathing
Number of subjects: 43
Study 22339103 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study 20033621 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial EMRs
Number of subjects: 60
Study 17495198 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein-acute meal (HP-AM)
Number of subjects: 38
Study 17495198 — intervention group
Group type: COMPARATOR
Intervention: Normal protein-acute meal (NP-AM)
Number of subjects: 38
Study 17495198 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein-chronic diet (HP-CD)
Number of subjects: 38
Study 17495198 — intervention group
Group type: COMPARATOR
Intervention: Normal protein-chronic diet (NP-CD)
Number of subjects: 38
Study 17495198 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein-acute meal (HP-AM) in HP-CD
Number of subjects: 38
Study 17495198 — intervention group
Group type: COMPARATOR
Intervention: Normal protein-acute meal (NP-AM) in NP-CD
Number of subjects: 38
Study 16213322 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol therapy (group 1, n = 57)
Number of subjects: 110
Study 12165477 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 0
Study 12165477 — intervention group
Group type: COMPARATOR
Intervention: Anticholinergic drug (0.4 mg iv scopolamine)
Number of subjects: 0
Study 9885795 — intervention group
Group type: EXPERIMENTAL
Intervention: m-CPP (0.4 mg/kg)
Number of subjects: 24
Study 9885795 — intervention group
Group type: EXPERIMENTAL
Intervention: ipsapirone (0.3 mg/kg)
Number of subjects: 24
Study 9885795 — intervention group
Group type: EXPERIMENTAL
Intervention: m-CPP or ipsapirone
Number of subjects: 24
Study 9885795 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study 8736278 — intervention group
Group type: EXPERIMENTAL
Intervention: Turner's syndrome
Number of subjects: 120
Study 8736278 — intervention group
Group type: EXPERIMENTAL
Intervention: Other forms of primary amenorrhoea
Number of subjects: 120
Study 8736278 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 120
Study 2044333 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil infusion at 10 micrograms/L
Number of subjects: 8
Study 2044333 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil infusion at 20 micrograms/L
Number of subjects: 8
Study 2044333 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 8
Study 2044333 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil infusion
Number of subjects: 8
Study 2044333 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam infusion
Number of subjects: 8
Study 7345027 — intervention group
Group type: EXPERIMENTAL
Intervention: Empathy training
Number of subjects: 28
Study 7345027 — intervention group
Group type: COMPARATOR
Intervention: Discussion control group
Number of subjects: 28
Study 7345027 — intervention group
Group type: COMPARATOR
Intervention: Testing control group
Number of subjects: 28
Study 31168863 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity breaks and mathematics combined
Number of subjects: 87
Study 31168863 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity breaks
Number of subjects: 87
Study 31168863 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 87
Study 30797389 — intervention group
Group type: EXPERIMENTAL
Intervention: Happiness exercises (5 brief self-administered exercises)
Number of subjects: 531
Study 30797389 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliving Happy Moments exercise
Number of subjects: 531
Study 30797389 — intervention group
Group type: EXPERIMENTAL
Intervention: Savoring exercise
Number of subjects: 531
Study 30797389 — intervention group
Group type: EXPERIMENTAL
Intervention: Rose, Thorn, Bud exercise
Number of subjects: 531
Study 30797389 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 Good Things exercise
Number of subjects: 531
Study 30797389 — intervention group
Group type: COMPARATOR
Intervention: 3 Hard Things exercise
Number of subjects: 531
Study 28459989 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental intervention (EX): Usual care (nutrition and PA education materials) plus 2‐month supervised weekly physical activity and behaviour change sessions.
Number of subjects: 112
Study 28459989 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC): Nutrition and PA education materials.
Number of subjects: 112
Study 25877812 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie Restriction (CR)
Number of subjects: 52
Study 25877812 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 52
Study 25877812 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie Restriction and Exercise (CREX)
Number of subjects: 52
Study 25877812 — intervention group
Group type: COMPARATOR
Intervention: Control (CR and EX)
Number of subjects: 52
Study 23624641 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study 23624641 — intervention group
Group type: COMPARATOR
Intervention: Naltrexone (opioid blockade)
Number of subjects: 146
Study 22922846 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (IVR)
Number of subjects: 55
Study 22922846 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal bevacizumab (IVB)
Number of subjects: 55
Study 20671330 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation-guided imagery (R-GI)
Number of subjects: 59
Study 20671330 — intervention group
Group type: COMPARATOR
Intervention: Usual-care (UC)
Number of subjects: 59
Study 17244232 — intervention group
Group type: EXPERIMENTAL
Intervention: Nociceptive trigeminal inhibitory (NTI) splint
Number of subjects: 10
Study 17244232 — intervention group
Group type: COMPARATOR
Intervention: Standard flat occlusal splint (OS)
Number of subjects: 10
Study 14964925 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention targeting rural providers and their practice environment
Number of subjects: 881
Study 14964925 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 881
Study 11461772 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU) + Vitamin C (1000 mg)
Number of subjects: 20
Study 11461772 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E (400 IU) alone
Number of subjects: 20
Study 9492719 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylergometrine 0.125 mg three times a day for three days
Number of subjects: 217
Study 9492719 — intervention group
Group type: COMPARATOR
Intervention: Placebo three times a day for three days
Number of subjects: 217
Study 7984652 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% naproxen gel
Number of subjects: 64
Study 7984652 — intervention group
Group type: COMPARATOR
Intervention: 1% diclophenac gel
Number of subjects: 64
Study 7984652 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 64
Study 3378552 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile method
Number of subjects: 33
Study 3378552 — intervention group
Group type: COMPARATOR
Intervention: Visual method
Number of subjects: 33
Study 3378552 — intervention group
Group type: COMPARATOR
Intervention: Spring method
Number of subjects: 33
Study 29221795 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol hydrochloride 25 mg
Number of subjects: 50
Study 29221795 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine hydrochloride 20 mg
Number of subjects: 50
Study 28564127 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (1-4 μg/kg/h) for 5 days
Number of subjects: 50
Study 28564127 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 50
Study 25443279 — intervention group
Group type: EXPERIMENTAL
Intervention: ProRoot MTA
Number of subjects: 46
Study 25443279 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocem
Number of subjects: 46
Study 25443279 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 46
Study 25443279 — intervention group
Group type: COMPARATOR
Intervention: Comparison between ProRoot MTA and Endocem
Number of subjects: 46
Study 22864764 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal sacrocolpopexy (ASCP)
Number of subjects: 0
Study 22864764 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sacrocolpopexy (LSCP)
Number of subjects: 0
Study 17138275 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraction pattern with random directional pattern in 3-month-olds
Number of subjects: 2
Study 17138275 — intervention group
Group type: EXPERIMENTAL
Intervention: Expansion pattern with random directional pattern in 3-month-olds
Number of subjects: 2
Study 17138275 — intervention group
Group type: EXPERIMENTAL
Intervention: Expansion/contraction patterns in 2-month-olds
Number of subjects: 2
Study 15055413 — intervention group
Group type: EXPERIMENTAL
Intervention: Care recommendation (CR) letter intervention
Number of subjects: 188
Study 10686803 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of lisinopril (32.5-35 mg/daily)
Number of subjects: 3164
Study 10686803 — intervention group
Group type: COMPARATOR
Intervention: Low doses of lisinopril (2.5-5 mg/daily)
Number of subjects: 3164
Study 8705223 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide
Number of subjects: 222
Study 8705223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study 1912370 — intervention group
Group type: EXPERIMENTAL
Intervention: Bestatin immunotherapy combined with remission maintenance chemotherapy
Number of subjects: 0
Study 1912370 — intervention group
Group type: EXPERIMENTAL
Intervention: Bestatin immunotherapy
Number of subjects: 0
Study 6125181 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 0
Study 6125181 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 0
Study 31096780 — intervention group
Group type: EXPERIMENTAL
Intervention: Supporting Teens with Autism on Relationships program (interventionist‐led parent group)
Number of subjects: 84
Study 31096780 — intervention group
Group type: EXPERIMENTAL
Intervention: Supporting Teens with Autism on Relationships program (parent self‐guided)
Number of subjects: 84
Study 31096780 — intervention group
Group type: COMPARATOR
Intervention: Attentional control group (substance abuse prevention program)
Number of subjects: 84